ATYR Performance & Benchmarks - 141% in 12m
The Total Return for 3m is 40.7%, for 6m 31.7% and YTD 29.8%. Compare with Peer-Group: Biotechnology
Performance Rating
6.68%
#29 in Peer-Group
Rel. Strength
96.15%
#297 in Stock-Universe
Total Return 12m
141.03%
#11 in Peer-Group
Total Return 5y
20.51%
#30 in Peer-Group
P/E | Value |
---|---|
P/E Trailing | - |
P/E Forward | - |
High / Low | USD |
---|---|
52 Week High | 6.61 USD |
52 Week Low | 1.72 USD |
Sentiment | Value |
---|---|
VRO Trend Strength +-100 | 8.57 |
Buy/Sell Signal +-5 | 1.05 |
Support / Resistance | Levels |
---|---|
Support | |
Resistance |
12m Total Return: ATYR (141%) vs XBI (-12.9%)

5y Drawdown (Underwater) Chart

Top Performer in Biotechnology
Short Term Performance
Symbol | 1w | 1m | 3m |
---|---|---|---|
ATYR | -19.4% | -8.38% | 40.7% |
ABVX | 8.20% | 839% | 941% |
ABVX | 7.37% | 827% | 843% |
PROK | -14.3% | 399% | 230% |
Long Term Performance
Symbol | 6m | 12m | 5y |
---|---|---|---|
ATYR | 31.7% | 141% | 20.5% |
RGC | 0.0% | 5,431% | 4,594% |
DRUG | -9.72% | 2,824% | 24.6% |
ABVX | 1,111% | 512% | 520% |
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
---|---|---|---|---|---|---|---|---|
GILD NASDAQ Gilead Sciences |
1.3% | 52.7% | 92.8% | 23.8 | 14.3 | 0.24 | 13.8% | 4.55% |
UTHR NASDAQ United Therapeutics |
1.16% | -10.2% | 153% | 11.2 | 10.9 | 1.43 | 72.0% | 9.29% |
AMGN NASDAQ Amgen |
2.19% | -8.66% | 40.3% | 28.1 | 14.8 | 1.03 | -30.1% | 9.31% |
NBIX NASDAQ Neurocrine Biosciences |
0.71% | -15.8% | 4.8% | 43.5 | 26.5 | 0.27 | -26.3% | 15.4% |
BIM PA Biomerieux |
5.8% | 27.4% | -7.28% | 32.6 | 25.9 | 1.56 | -45.1% | -33.6% |
PTCT NASDAQ PTC Therapeutics |
7.29% | 59.5% | 9.36% | 7.57 | 5.51 | 0.81 | - | 88.6% |
KMDA NASDAQ Kamada |
-6.96% | 34.1% | -17.7% | 26.5 | 23.9 | 0.89 | 60.0% | 40.6% |
LONN SW Lonza |
1.42% | 3.02% | 1.21% | 54.5 | 34.5 | 1.29 | 5.20% | -7.55% |
Performance Comparison: ATYR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ATYR
Total Return (including Dividends) | ATYR | XBI | S&P 500 |
---|---|---|---|
1 Month | -8.38% | 3.43% | 0.66% |
3 Months | 40.72% | 4.17% | 11.66% |
12 Months | 141.03% | -12.88% | 15.92% |
5 Years | 20.51% | -24.27% | 103.09% |
Trend Stabilty (consistency of price movement) | ATYR | XBI | S&P 500 |
---|---|---|---|
1 Month | -8.9% | -1.2% | 66.4% |
3 Months | 72.7% | 86.5% | 96.6% |
12 Months | 79.3% | -84.7% | 50% |
5 Years | -48.8% | -50.4% | 84% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
---|---|---|---|
1 Month | 21 %th | -11.42% | -8.98% |
3 Month | 78 %th | 35.09% | 26.03% |
12 Month | 96 %th | 176.67% | 107.92% |
5 Years | 86 %th | 59.13% | -40.66% |
FAQs
Does aTyr Pharma (ATYR) outperform the market?
Yes,
over the last 12 months ATYR made 141.03%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.88%.
Over the last 3 months ATYR made 40.72%, while XBI made 4.17%.
Performance Comparison ATYR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ATYR vs. Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -17% | -9% | 27% | 125% |
US NASDAQ 100 | QQQ | -17.2% | -9.6% | 24.5% | 120% |
German DAX 40 | DAX | -16.1% | -7.3% | 22.8% | 112% |
Shanghai Shenzhen CSI 300 | CSI 300 | -16.8% | -11.1% | 22.7% | 120% |
Hongkong Hang Seng | HSI | -17.2% | -10.5% | 4.3% | 102% |
India NIFTY 50 | INDA | -17.4% | -2.8% | 28.1% | 148% |
Brasil Bovespa | EWZ | -18.3% | -1% | 24.7% | 137% |
ATYR vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -18% | -6.9% | 27.7% | 116% |
Consumer Discretionary | XLY | -15.5% | -7.4% | 36.9% | 122% |
Consumer Staples | XLP | -17.7% | -6.2% | 29.3% | 136% |
Energy | XLE | -17.7% | -8.5% | 33% | 144% |
Financial | XLF | -15.6% | -6% | 30.7% | 120% |
Health Care | XLV | -15.5% | -4.3% | 41.9% | 153% |
Industrial | XLI | -16% | -9.6% | 21.7% | 120% |
Materials | XLB | -13.3% | -4.7% | 33.1% | 145% |
Real Estate | XLRE | -15.9% | -7.4% | 30.3% | 139% |
Technology | XLK | -17.5% | -10.8% | 18.4% | 118% |
Utilities | XLU | -20.9% | -13.1% | 20.5% | 122% |
Aerospace & Defense | XAR | -16.6% | -12.5% | 8.9% | 95% |
Biotech | XBI | -17.5% | -11.8% | 37.6% | 154% |
Homebuilder | XHB | -16.9% | -9.6% | 32.9% | 150% |
Retail | XRT | -14.6% | -6.5% | 32.4% | 138% |
ATYR vs. Commodities
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Oil | USO | -22.9% | -13.2% | 32.1% | 140% |
Natural Gas | UNG | -17.9% | 1.5% | 54.4% | 137% |
Gold | GLD | -19.9% | -8.9% | 12.7% | 104% |
Silver | SLV | -16.3% | -11% | 14.5% | 112% |
Copper | CPER | 3.7% | 4.3% | 30.1% | 133% |
ATYR vs. Bonds
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
iShares 20+ Years Bond | TLT | -21% | -8% | 30.2% | 145% |
iShares High Yield Corp. Bond | HYG | -18.8% | -8.1% | 28.3% | 133% |